UBS Group’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-5,089,745
| Closed | -$385M | – | 10691 |
|
|
2026
Q1 | $385M | Buy |
5,089,745
+1,950,084
| +62% | +$147M | 0.06% | 339 |
|
|
2025
Q4 | $234M | Buy |
3,139,661
+684,637
| +28% | +$50M | 0.04% | 501 |
|
|
2025
Q3 | $166M | Buy |
2,455,024
+1,111,720
| +83% | +$73.8M | 0.03% | 691 |
|
|
2025
Q2 | $87.5M | Sell |
1,343,304
-1,195,231
| -47% | -$71.6M | 0.02% | 1061 |
|
|
2025
Q1 | $157M | Buy |
2,538,535
+1,168,033
| +85% | +$77.4M | 0.03% | 646 |
|
|
2024
Q4 | $98.8M | Buy |
1,370,502
+439,640
| +47% | +$34.3M | 0.02% | 940 |
|
|
2024
Q3 | $75.8M | Buy |
930,862
+161,592
| +21% | +$12.9M | 0.02% | 891 |
|
|
2024
Q2 | $57.1M | Buy |
769,270
+58,693
| +8% | +$4.4M | 0.01% | 950 |
|
|
2024
Q1 | $55.4M | Buy |
710,577
+348,936
| +96% | +$26M | 0.01% | 983 |
|
|
2023
Q4 | $25.8M | Buy |
361,641
+93,756
| +35% | +$6.53M | 0.01% | 1415 |
|
|
2023
Q3 | $18.6M | Sell |
267,885
-12,731
| -5% | -$962K | 0.01% | 1541 |
|
|
2023
Q2 | $22.7M | Sell |
280,616
-106,774
| -28% | -$8.73M | 0.01% | 1355 |
|
|
2023
Q1 | $31.3M | Buy |
387,390
+15,061
| +4% | +$1.21M | 0.01% | 1066 |
|
|
2022
Q4 | $27.9M | Buy |
372,329
+294,983
| +381% | +$21M | 0.01% | 1190 |
|
|
2022
Q3 | $4.99M | Sell |
77,346
-72,061
| -48% | -$4.99M | ﹤0.01% | 2345 |
|
|
2022
Q2 | $10.4M | Buy |
149,407
+35,559
| +31% | +$2.64M | ﹤0.01% | 1792 |
|
|
2022
Q1 | $8.75M | Sell |
113,848
-219,701
| -66% | -$15.8M | ﹤0.01% | 2040 |
|
|
2021
Q4 | $25.5M | Sell |
333,549
-77,064
| -19% | -$5.66M | 0.01% | 1416 |
|
|
2021
Q3 | $30.3M | Buy |
410,613
+90,347
| +28% | +$6.78M | 0.01% | 1174 |
|
|
2021
Q2 | $21.4M | Buy |
320,266
+6,554
| +2% | +$438K | 0.01% | 1443 |
|
|
2021
Q1 | $23.3M | Sell |
313,712
-103,528
| -25% | -$7.86M | 0.01% | 1334 |
|
|
2020
Q4 | $30.4M | Buy |
417,240
+213,776
| +105% | +$15.1M | 0.01% | 1081 |
|
|
2020
Q3 | $13.5M | Buy |
203,464
+14,447
| +8% | +$914K | 0.01% | 1439 |
|
|
2020
Q2 | $10.8M | Sell |
189,017
-39,689
| -17% | -$1.95M | ﹤0.01% | 1446 |
|
|
2020
Q1 | $8.03M | Sell |
228,706
-239,452
| -51% | -$11.4M | ﹤0.01% | 1560 |
|
|
2019
Q4 | $24.4M | Buy |
468,158
+68,271
| +17% | +$3.4M | 0.01% | 1232 |
|
|
2019
Q3 | $20.2M | Buy |
399,887
+43,392
| +12% | +$2.14M | 0.01% | 1233 |
|
|
2019
Q2 | $17.1M | Buy |
356,495
+56,156
| +19% | +$2.6M | 0.01% | 1319 |
|
|
2019
Q1 | $14.5M | Buy |
300,339
+199,651
| +198% | +$9M | 0.01% | 1377 |
|
|
2018
Q4 | $4.14M | Buy |
100,688
+733
| +0.7% | +$30.1K | ﹤0.01% | 2329 |
|
|
2018
Q3 | $4.1M | Sell |
99,955
-17,780
| -15% | -$719K | ﹤0.01% | 2534 |
|
|
2018
Q2 | $4.68M | Sell |
117,735
-13,872
| -11% | -$534K | ﹤0.01% | 2401 |
|
|
2018
Q1 | $4.92M | Sell |
131,607
-206,793
| -61% | -$8.36M | ﹤0.01% | 2327 |
|
|
2017
Q4 | $14.5M | Buy |
338,400
+146,168
| +76% | +$5.83M | 0.01% | 1424 |
|
|
2017
Q3 | $7.05M | Sell |
192,232
-178,951
| -48% | -$7.22M | ﹤0.01% | 1888 |
|
|
2017
Q2 | $16.8M | Sell |
371,183
-380,634
| -51% | -$16.8M | 0.01% | 1152 |
|
|
2017
Q1 | $32M | Buy |
751,817
+67,030
| +10% | +$2.73M | 0.02% | 749 |
|
|
2016
Q4 | $27.5M | Buy |
684,787
+6,064
| +0.9% | +$234K | 0.02% | 837 |
|
|
2016
Q3 | $26.4M | Buy |
678,723
+27,633
| +4% | +$1.04M | 0.02% | 810 |
|
|
2016
Q2 | $22.5M | Sell |
651,090
-143,661
| -18% | -$4.97M | 0.01% | 868 |
|
|
2016
Q1 | $27.4M | Buy |
794,751
+45,652
| +6% | +$1.59M | 0.02% | 710 |
|
|
2015
Q4 | $29M | Buy |
749,099
+141,639
| +23% | +$5.51M | 0.02% | 752 |
|
|
2015
Q3 | $23.8M | Buy |
607,460
+504,651
| +491% | +$20M | 0.02% | 788 |
|
|
2015
Q2 | $3.91M | Buy |
102,809
+1,057
| +1% | +$37K | ﹤0.01% | 2328 |
|
|
2015
Q1 | $3.36M | Sell |
101,752
-7,979
| -7% | -$245K | ﹤0.01% | 2431 |
|
|
2014
Q4 | $2.93M | Buy |
+109,731
| New | +$2.83M | ﹤0.01% | 2549 |
|
Other funds holding HOLX
UBS Group's HOLX Position: Q2 2026 in Review
UBS Group sold out of Hologic (HOLX) in Q2 2026, closing a stake of 5,089,745 shares — an estimated $385M sold.
UBS Group first reported a position in HOLX in Q4 2014 and held it in 46 quarters. The position peaked at $385M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- UBS Group reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- UBS Group sold 5,089,745 Hologic shares in Q2 2026, an estimated $385M.
- UBS Group first reported a position in Hologic in Q4 2014 and held it in 46 quarters.
- UBS Group's Hologic position peaked at $385M in Q1 2026.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.